Cargando…
Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
BACKGROUND: Huai Hua San (HHS), a famous Traditional Chinese Medicine (TCM) formula, has been widely applied in treating ulcerative colitis (UC). However, the interaction of bioactives from HHS with the targets involved in UC has not been elucidated yet. AIM: A network pharmacology-based approach co...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326529/ https://www.ncbi.nlm.nih.gov/pubmed/34349502 http://dx.doi.org/10.2147/DDDT.S319786 |
_version_ | 1783731848543731712 |
---|---|
author | Liu, Jiaqin Liu, Jian Tong, Xiaoliang Peng, Weijun Wei, Shanshan Sun, Taoli Wang, Yikun Zhang, Bikui Li, Wenqun |
author_facet | Liu, Jiaqin Liu, Jian Tong, Xiaoliang Peng, Weijun Wei, Shanshan Sun, Taoli Wang, Yikun Zhang, Bikui Li, Wenqun |
author_sort | Liu, Jiaqin |
collection | PubMed |
description | BACKGROUND: Huai Hua San (HHS), a famous Traditional Chinese Medicine (TCM) formula, has been widely applied in treating ulcerative colitis (UC). However, the interaction of bioactives from HHS with the targets involved in UC has not been elucidated yet. AIM: A network pharmacology-based approach combined with molecular docking and in vitro validation was performed to determine the bioactives, key targets, and potential pharmacological mechanism of HHS against UC. MATERIALS AND METHODS: Bioactives and potential targets of HHS, as well as UC-related targets, were retrieved from public databases. Crucial bioactive ingredients, potential targets, and signaling pathways were acquired through bioinformatics analysis, including protein–protein interaction (PPI), as well as the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Subsequently, molecular docking was carried out to predict the combination of active compounds with core targets. Lastly, in vitro experiments were conducted to further verify the findings. RESULTS: A total of 28 bioactive ingredients of HHS and 421 HHS-UC-related targets were screened. Bioinformatics analysis revealed that quercetin, luteolin, and nobiletin may be potential candidate agents. JUN, TP53, and ESR1 could become potential therapeutic targets. PI3K-AKT signaling pathway might play an important role in HHS against UC. Moreover, molecular docking suggested that quercetin, luteolin, and nobiletin combined well with JUN, TP53, and ESR1, respectively. Cell experiments showed that the most important ingredient of HHS, quercetin, could inhibit the levels of inflammatory factors and phosphorylated c-Jun, as well as PI3K-Akt signaling pathway in LPS-induced RAW264.7 cells, which further confirmed the prediction by network pharmacology strategy and molecular docking. CONCLUSION: Our results comprehensively illustrated the bioactives, potential targets, and molecular mechanism of HHS against UC. It also provided a promising strategy to uncover the scientific basis and therapeutic mechanism of TCM formulae in treating diseases. |
format | Online Article Text |
id | pubmed-8326529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-83265292021-08-03 Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis Liu, Jiaqin Liu, Jian Tong, Xiaoliang Peng, Weijun Wei, Shanshan Sun, Taoli Wang, Yikun Zhang, Bikui Li, Wenqun Drug Des Devel Ther Original Research BACKGROUND: Huai Hua San (HHS), a famous Traditional Chinese Medicine (TCM) formula, has been widely applied in treating ulcerative colitis (UC). However, the interaction of bioactives from HHS with the targets involved in UC has not been elucidated yet. AIM: A network pharmacology-based approach combined with molecular docking and in vitro validation was performed to determine the bioactives, key targets, and potential pharmacological mechanism of HHS against UC. MATERIALS AND METHODS: Bioactives and potential targets of HHS, as well as UC-related targets, were retrieved from public databases. Crucial bioactive ingredients, potential targets, and signaling pathways were acquired through bioinformatics analysis, including protein–protein interaction (PPI), as well as the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Subsequently, molecular docking was carried out to predict the combination of active compounds with core targets. Lastly, in vitro experiments were conducted to further verify the findings. RESULTS: A total of 28 bioactive ingredients of HHS and 421 HHS-UC-related targets were screened. Bioinformatics analysis revealed that quercetin, luteolin, and nobiletin may be potential candidate agents. JUN, TP53, and ESR1 could become potential therapeutic targets. PI3K-AKT signaling pathway might play an important role in HHS against UC. Moreover, molecular docking suggested that quercetin, luteolin, and nobiletin combined well with JUN, TP53, and ESR1, respectively. Cell experiments showed that the most important ingredient of HHS, quercetin, could inhibit the levels of inflammatory factors and phosphorylated c-Jun, as well as PI3K-Akt signaling pathway in LPS-induced RAW264.7 cells, which further confirmed the prediction by network pharmacology strategy and molecular docking. CONCLUSION: Our results comprehensively illustrated the bioactives, potential targets, and molecular mechanism of HHS against UC. It also provided a promising strategy to uncover the scientific basis and therapeutic mechanism of TCM formulae in treating diseases. Dove 2021-07-28 /pmc/articles/PMC8326529/ /pubmed/34349502 http://dx.doi.org/10.2147/DDDT.S319786 Text en © 2021 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Liu, Jiaqin Liu, Jian Tong, Xiaoliang Peng, Weijun Wei, Shanshan Sun, Taoli Wang, Yikun Zhang, Bikui Li, Wenqun Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis |
title | Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis |
title_full | Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis |
title_fullStr | Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis |
title_full_unstemmed | Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis |
title_short | Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis |
title_sort | network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of huai hua san against ulcerative colitis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326529/ https://www.ncbi.nlm.nih.gov/pubmed/34349502 http://dx.doi.org/10.2147/DDDT.S319786 |
work_keys_str_mv | AT liujiaqin networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis AT liujian networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis AT tongxiaoliang networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis AT pengweijun networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis AT weishanshan networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis AT suntaoli networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis AT wangyikun networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis AT zhangbikui networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis AT liwenqun networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis |